Danish children hospitalized by super strength Inno Pharma vitamin D

By Gareth Macdonald contact

- Last updated on GMT

Danish children hospitalized by super strength Inno Pharma vitamin D
Several children have been hospitalized by a vitamin D supplement made by Inno Pharma according to regulators in Denmark.

The Danish Health Authority (Sundhedsstyrelsen) advised people not to use "Inno Pharma vitamin D3-dråber" – sold by health food organization Helsam or pharmacy chain Matas – in a warning letter published on July 29​.

An authority spokeswoman told us “Due to a calculation error the company Inno Pharma has produced a vitamin D food supplement with a 75 times higher dose than intended​” adding that “production has been stopped and the sold products has been recalled​”

She also confirmed that “several young children have been hospitalized as a result of ingesting this particular food supplement​.”  

According to the organization 87 of the 150 children known to have used the super strength product had elevated vitamin D levels.

High vitamin D levels may result in a condition called hypercalcemia – high blood calcium – which is known to interfere with normal cardiac functioning. It is also linked to the formation of kidney stones.

According to Sundhedsstyrelsen, 74 of the children tested had high levels in their blood.

Inno Pharma is not associated with Pfizer’s InnoPharma subsidiary.

Related news

Related products

show more

Skin-Gut Axis: The Potential of Pomella®

Skin-Gut Axis: The Potential of Pomella®

Gee Lawson Nutritional - LEHVOSS Group | 02-Nov-2018 | Technical / White Paper

When skin is exposed to oxidative stress, the effectiveness of the endogenic antioxidant system can be significantly compromised. Pomegranate, a natural...

K2 for Heart Health? MenaQ7 Only Proven, Patented

K2 for Heart Health? MenaQ7 Only Proven, Patented

NattoPharma USA, Inc. | 22-Oct-2018 | Research Study

Vitamin K2 has earned media and the medical community’s attention due to a strong body of evidence showing it simultaneously supports bone and cardiovascular...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars